Congrats to the @sensible_bio team on the launch and new partnership with @Ginkgo! Sensible (YC S21) engineers cells to produce high-quality mRNA in a scalable and cost-efficient way, to meet the growing demand for mRNA in novel vaccines and therapies. forbes.com/sites/johncumb…
2
5
51
19K
3
@ycombinator @sensible_bio @Ginkgo Are there any prospects for cash revenue generation? If so, from whom and on what timelines?